H-P Restates First Quarter Numbers

The world’s largest computer maker Hewlett-Packard Company (NYSE:HPQ) recently came out with a revised version of its first quarter 2010 earnings, whereby the company lowered its net profit by $73.0...

Tags:

BNY Mellon Acquires BHF

As part of its initiative to expand its global market share, Bank of New York Mellon Corp. (NYSE:BK) is acquiring Germany’s BHF Asset Servicing GmbH for $343 million. The deal, which is expected...

Tags:

WNR Loss Narrows But Stays “Sell”

Oil refiner and marketer Western Refining Inc. (NYSE:WNR) reported better-than-expected fourth quarter results, helped by higher sales volumes. Its loss per share, excluding special items, came in at ...

Tags:

Merck Ests Revised Downward

Earnings estimates for Merck & Co. (NYSE:MRK) are on the lower side following the release of fourth quarter and full-year 2009 results. The company’s earnings per share (EPS) came in at 79 cents...

Tags:

Genomic Health Stays At Neutral

We maintain our Neutral recommendation on Genomic Health Inc. (NASDAQ:GHDX) with a target price of $20.00.   Genomic Health, founded in 2000 and headquartered in Redwood City, California, is an o...

Tags:

Collective Brands Tops Estimates

Collective Brands, Inc. (NYSE:PSS), the wholesaler and retailer of footwear and related accessories, recently posted fourth-quarter 2009 results that topped the Zacks expectation on the heels of a str...

Tags:

Brown-Forman Reports Strong Sales

Brown-Forman Corp. (BF.A), one of the leading producers and distributors of premium alcoholic beverages in the world, posted fiscal 2010 third-quarter earnings of $107.9 million or $0.73 per share, co...

Tags:

Stock Buy: SanDisk Corp

SanDisk Corp (NASDAQ:SNDK) recently raised its outlook, shares and estimates have responded favorable. Company Description SanDisk Corp. makes memory-based semiconductors for a variety of consumer ele...

Tags:

ABM Lags Zacks Consensus

ABM Industries Inc. (NYSE:ABM) recently reported fiscal first-quarter earnings of 27 cents per share, which is below the Zacks Consensus Estimate of 32 cents, but higher than the prior year earnings o...

Tags:

Allos Extends Losses

Allos Therapeutics’ (NASDAQ:ALTH) fourth quarter loss per share came in at 22 cents, worse than the Zacks Consensus Estimate of 20 cents and a loss of 18 cents reported in the year-ago period. For 2...

Tags: